{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:31:01Z","timestamp":1790872261451,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002835.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":33,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002835.pub3","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure"],"prefix":"10.1002","volume":"2012","author":[{"given":"Taryn","family":"Young","sequence":"first","affiliation":[{"name":"Stellenbosch University; Centre for Evidence-based Health Care, Faculty of Health Sciences; PO Box 19063 Tygerberg South Africa 7505"},{"name":"South African Medical Research Council; South African Cochrane Centre; PO Box 19070 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanelo James","family":"Arens","sequence":"additional","affiliation":[{"name":"Groote Schuur Hospital; Clinical Pharmacology; 45- Old Main Building Groote Schuur Hospital Observatory, Cape Town Western Cape South Africa 7925"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E","family":"Kennedy","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street Suite 1200 San Francisco California USA 94105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Laurie","sequence":"additional","affiliation":[{"name":"Aberdeen University; Medical faculty; Facuty of Medicine and Medical Sciences Polworth Building, Foresterhill Aberdeen Aberdeenshire UK AB25 2ZD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W","family":"Rutherford","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; 50 Beale Street Suite 1200 San Francisco California USA 94105"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"21","key":"10.1002\/14651858.CD002835.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure","volume":"337","author":"Cardo","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/00002030-200010200-00026","article-title":"Effects of short-course of antiretroviral agents on serum triglycerides of healthy individuals","volume":"14","author":"Italian Registry of Antiretroviral Post-exposure","year":"2000","journal-title":"AIDS"},{"issue":"9205","key":"10.1002\/14651858.CD002835.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0140-6736(99)05005-9","article-title":"Tolerability and side-effects of post-exposure prophylaxis for HIV infection","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0140-6736(05)74610-9","article-title":"Post-exposure prophylaxis for HIV infection","volume":"355","author":"Puro","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1097\/00002030-200309050-00020","article-title":"Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis","volume":"17","author":"Puro","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/426692","article-title":"Postexposure HIV prophylaxis regimen","volume":"40","author":"Puro","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0007|cit7","unstructured":"Srivastava P Cardo DM Panlilio A Campbell S Tolerability of antiretroviral agents used by health-care workers (HCWs) as post-exposure prophylaxis (PEP) for occupational exposures to HIV Int Conf AIDS, 12:626 (abstract no. 246\/33171) 1998"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00043764-199812000-00010","article-title":"Occupational exposure to HIV: experience at a tertiary care center","volume":"40","author":"Swotinsky","year":"1998","journal-title":"J Occup and Environ Med"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/501736","article-title":"Experience of Healthcare Workers Taking Postexposure Prophylaxis after Occupational exposures: findings of the HIV Postexposure Prophylaxis Registry","volume":"21","author":"Wang","year":"2000","journal-title":"Infect Control Hosp Epidemiology"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/422459","article-title":"Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV","volume":"39","author":"Bassett","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1002\/14651858.CD002835.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002030-199702000-00004","article-title":"Prevention of simian immunodeficiency virus, SIVsm, or HIV2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005","volume":"11","author":"Bottinger","year":"1997","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD002835.pub3-BIB0012|cit12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003510","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection","author":"Brocklehurst","year":"2002","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"RR-17","key":"10.1002\/14651858.CD002835.pub3-BIB0013|cit13","first-page":"1","article-title":"Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy","volume":"47","author":"Center for Disease Control and Prevention","year":"1998","journal-title":"MMWR"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0014|cit14","unstructured":"Center for Disease Control and Prevention Updated U.S Public health service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for postexposure prophylaxis MMWR 2001"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0015|cit15","unstructured":"Center for Disease Control and Prevention Updated U.S. Public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis MMWR 2005"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMcp020892","article-title":"Occupational exposure to HIV in health care settings","volume":"348","author":"Gerberding","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0017|cit17","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0018|cit18","unstructured":"Kaldor J Peer review comments on PEP proposal e-mail 2000"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200124080-00003","article-title":"Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV","volume":"24(8)","author":"Lee","year":"2001","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0020|cit20","unstructured":"Loke YK Price D Herxheimer A on behalf of the Cochrane Adverse Effects Subgroup. Including adverse events. In: Higgins JPT Green S www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0021|cit21","first-page":"325","article-title":"A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk","volume":"14","author":"Low-Beer","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002835.pub3-BIB0022|cit22","article-title":"Effectiveness and safety of HIV post-exposure prophylaxis after sexual, injecting-drug-use or other non-occupational exposure (Protocol)","author":"Mart\u00edn","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0023|cit23","unstructured":"Miller S Lo B Lurie P Non-occupational post-exposure HIV prophylaxis: guidelines for clinicians Writing Seminar 1996"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/JVI.74.13.5747-5753.2000","article-title":"Suppression of acute viremia by short-term postexposure prophylaxis of simian\/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection","volume":"74","author":"Mori","year":"2000","journal-title":"J Virol"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00002030-199809000-00015","article-title":"Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV","volume":"12","author":"Pinkerton","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00002030-200002180-00016","article-title":"Is post-exposure prophylaxis affordable?","volume":"14","author":"Pinkerton","year":"2000","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(03)14538-2","article-title":"Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial","volume":"362","author":"Taha","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002835.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0736-4679(98)00188-7","article-title":"Emergency department management of occupational exposures to HIV-infected fluids","volume":"17","author":"Torbati","year":"1999","journal-title":"J of Emerg Med"},{"issue":"4265-73","key":"10.1002\/14651858.CD002835.pub3-BIB0030|cit30","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0031|cit31","first-page":"1","article-title":"HIV\/AIDS prevention in the context of new therapies. Report of a meeting organized by UNAIDS and the AIDS Research Institute of the University of California at San Francisco","author":"Laporte","year":"1998","journal-title":"UNAIDS best practice collection"},{"issue":"5","key":"10.1002\/14651858.CD002835.pub3-BIB0032|cit32","first-page":"641","article-title":"Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service","volume":"162","author":"Weibe","year":"2000","journal-title":"Canad Med Assoc J"},{"key":"10.1002\/14651858.CD002835.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(98)12262-6","article-title":"Transmission of antiretroviral-drug-resistent HIV-1 variants","volume":"354","author":"Yerly","year":"1999","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002835.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T07:27:50Z","timestamp":1723620470000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002835.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002835.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}